scispace - formally typeset
L

Lance E. Rodewald

Researcher at Centers for Disease Control and Prevention

Publications -  125
Citations -  6334

Lance E. Rodewald is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Vaccination & Health care. The author has an hindex of 41, co-authored 112 publications receiving 6116 citations. Previous affiliations of Lance E. Rodewald include Government of the United States of America & World Health Organization.

Papers
More filters
Journal ArticleDOI

Reviews of evidence regarding interventions to improve vaccination coverage in children adolescents and adults.

TL;DR: In this paper, the authors present the results of systematic reviews of the effectiveness, applicability, other effects, economic impact, and barriers to use of selected population-based interventions intended to improve vaccination coverage.
Journal ArticleDOI

Effect of patient reminder/recall interventions on immunization rates: A review.

TL;DR: All types of reminders were effective in improving immunization rates, with telephone reminders being most effective but costliest, and primary care physicians should use patient reminders to improve immunization delivery.
Journal ArticleDOI

National, state and urban-area vaccination-coverage levels among children aged 19-35 months, United States, 1999.

TL;DR: In 1999, national coverage estimates were high for most vaccines and among most demographic groups, and state and urban-area level estimates varied.
Journal ArticleDOI

Does quality of care affect rates of hospitalization for childhood asthma

TL;DR: The quality of ambulatory care, including choice of preventive therapies and thresholds for admission, likely plays a key role in determining community hospitalization rates for chronic conditions such as childhood asthma.
Journal ArticleDOI

Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001

TL;DR: Routine childhood immunization with the 7 vaccines was cost saving from the direct cost and societal perspectives, with net savings of 9.9 billion dollars and 43.3 billion dollars, respectively.